Business
Silver Crown Royalties Announces Closing of Oversubscribed $3.3M Brokered Life Offering Led by Centurion One Capital
Toronto, Ontario--(Newsfile Corp. - October 6, 2025) - Silver Crown Royalties Inc. (Cboe CA: SCRI) (OTCQX: SLCRF) (FSE: QS0) ("Silver Crown", "SCRi", or the "Company") is pleased to announce the closing of its previously announced upsized financing of units ("Units") of the Company (the "Offering"). A total of 599,064 Units, including the exercise of the over-allotment option were sold under the Offering at a price of $5.50 per Unit (the "Issue Price") for aggregate gross proceeds of...
About this update from Silver Crown Royalties Inc
[{"type":"text","content":"Toronto, Ontario--(Newsfile Corp. - October 6, 2025) - Silver Crown Royalties Inc. (Cboe CA: SCRI) (OTCQX: SLCRF) (FSE: QS0) ("Silver Crown", "SCRi", or the "Company") is pleased to announce the closing of its previously announced upsized financing of units ("Units") of the Company (the "Offering"). A total of 599,064 Units, including the exercise of the over-allotment option were sold under the Offering at a price of $5.50 per Unit (the "Issue Price") for aggregate gross proceeds of $3,294,852.00. The Offering was led by Centurion One Capital Corp. as lead agent and sole bookrunner (the "Lead Agent").","length":704,"tagName":"p"},{"type":"text","content":"Peter Bures, Executive Chairman and Chief Executive Officer, commented: "Silver Crown Royalties is very pleased to close this oversubscribed financing. Investor demand surpassed our initial target, enabling us to increase the size of this offering. This new capital will allow us to secure new royalties, deliver shareholder value and continue to grow our portfolio."","length":377,"tagName":"p"},{"type":"text","content":"The Units were issued pursuant to Part 5A of National Instrument 45-106 - Prospectus Exemptions ("NI 45-106") and in reliance on the amendments to Part 5A of NI 45-106 set forth in Coordinated Blanket Order 45-935 - Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (collectively, the "Listed Issuer Financing Exemption"). Each Unit consists of one common share ("Common Share") and one Common Share purchase warrant (each whole warrant, a "Warrant"). Each Warrant entitles the holder to acquire one Common Share at a price of $8.25 for a period of 36 months from the closing of the Offering (the "Closing Date"). The Warrants will be subject to an acceleration right (the "Warrant Acceleration Right") if, on any thirty (30) consecutive trading days, beginning on the date that is the Closing Date the daily volume weighted average trading price of the Common Share is greater than $11.00. If the Company exercises its Warrant Acceleration Right, the new expiry date of the Warrants will be the 30th day following the notice of such exercise.","length":1129,"tagName":"p"},{"type":"text","c...